Table 1 Clinical characteristics and blood laboratory tests of AS patients and controls (excluding participants with positive urinary cultures - two in the AS group and one in the control group)
From: An investigation about chronic prostatitis in ankylosing spondylitis
AS (n = 43) | Controls (n = 44) | p | |
|---|---|---|---|
Age (years) | 52.5 ± 10.0 | 52.8 ± 12.1 | 0.882 |
Disease duration (years) | 12.4 ± 6.9 | ||
Anti-TNF treatment | 35 (86.0%) | ||
BASDAI | 4.9 ± 1.7 | ||
ASDAS | 2.7 ± 0.6 | ||
NIH-CPSI | 4.0 [1.0–12.0] | 5.0 [1.0–8.5] | 0.944 |
NIH-CPSI (Pain Domain) ≥ 4 | 10 (23.3%) | 10 (22.7%) | 0.953 |
NIH-CPSI (Pain Domain) ≥ 8 | 6 (14.0%) | 5 (11.4%) | 0.716 |
IPSS | 6 [2.5–13.5] | 2.5 [0.0–12.0] | 0.105 |
IPSS > 8 | 14 (32.6%) | 13 (29.5%) | 0.499 |
PSA (ng/mL) | 1.2 ± 1.1 | 1.8 ± 2.0 | 0.324 |
CRP (mg/L) | 3.2 [2.8–3.3] | 2.3 [1.0–2.6] | 0.011* |
ESR (mm/h) | 4 [3–5] | 3 [2–5] | 0.857 |
Uric acid (mg/dL) | 5.8 ± 1.3 | 5.5 ± 1.2 | 0.624 |